• Jason Kim, Yiping Li, and Azam Ahmed.
• Department of Neurological Surgery, University of Wisconsin-Madison School of Medicine, Madison, Wisconsin, USA. Electronic address: jjkim28@wisc.edu.
• World Neurosurg. 2019 Jul 1; 127: e556-e560.

BackgroundFlow-diverting stents (FDS) are relatively safe and highly efficacious in treating cerebral aneurysms; however, a small subset of patients experience devastating hemorrhagic complications owing to presumed alterations in local aneurysm and distal cerebral blood flow. The downstream effects of FDS on distal cerebral blood flow is not well understood, but isolated reports of hyperperfusion injury have been described in the literature. We investigate the incidence and clinical factors contributing to abnormal cerebral blood flow after FDS placement.MethodsA retrospective analysis of patients undergoing FDS for elective aneurysm treatment between 2014-2017 was performed. Patients who underwent perfusion imaging within 24-hours posttreatment were included for further analysis. Univariate and multivariate analyses were performed to assess the impact of multiple variables on the postoperative perfusion changes.ResultsA total of 69 patients underwent FDS therapy to treat unruptured intracranial aneurysms. Thirteen patients (18.8%) developed abnormal perfusion changes. A significant difference of the median was found in aneurysm projection width, depth, neck width, calculated approximate volume, and size ratio between the hypoperfused, normal, and hyperperfusion cases. On multivariate analysis, history of smoking (P = 0.0117), and approximate calculated volume (P = 0.0145) were significant predictors of hyperperfusion identified on posttreatment imaging.ConclusionsThis study yielded several novel findings. We demonstrate that cerebral blood flow alterations will occur in a significant subset of patients undergoing FDS treatment. We also provide new evidence that aneurysm volume and history of smoking may predict the developing of postoperative perfusion anomalies. Future studies are needed to evaluate the clinical ramifications of cerebral blood flow disruption in large prospective studies.Copyright © 2019 Elsevier Inc. All rights reserved.

3 keywords...

hide…